Biomarkers for the detection and prognosis of prostate cancer

被引：4
|
作者：
Hernandez J. [1 ]
Canby-Hagino E. [1 ]
Thompson I.M. [1 ]
机构：
[1] Department of Urology, University of Texas Health Sciences Center, Floyd Curl Drive, A7703, San Antonio, 78229, TX
来源：
Current Urology Reports | 2005年 / 6卷 / 3期
关键词：
Finasteride; Localize Prostate Cancer; Prostate Cancer; Radiation Therapy Oncology Group; Radical Prostatectomy;
D O I：
10.1007/s11934-005-0004-7
中图分类号：
学科分类号：
摘要：
Recent studies have cast doubt on the reliability of serum total prostate-specific antigen as a biomarker for the detection and prognosis of prostate cancer. Biomarkers that can identify those men at risk for clinically significant prostate cancer are desperately needed. The search for biomarkers that may improve the detection of biologically consequential prostate cancer is one of the most active areas under current investigation. In this review, we highlight some of these ongoing efforts. Proper validation of newly discovered biomarkers is of paramount importance. © 2005, Current Science Inc.
引用
收藏
页码：171 / 176
页数：5
相关论文
共 50 条
  • [31] Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer
    Eickelschulte, Samaneh
    Riediger, Anja Lisa
    Angeles, Arlou Kristina
    Janke, Florian
    Duensing, Stefan
    Sueltmann, Holger
    Goertz, Magdalena
    [J]. CANCERS, 2022, 14 (24)
  • [32] Detection of prostate cancer using a panel of epigenetic biomarkers
    Dumache, R.
    Minciu, R.
    David, D.
    Kaycsa, A.
    Ionescu, D.
    Puiu, M.
    [J]. TOXICOLOGY LETTERS, 2011, 205 : S63 - S63
  • [33] Prostate Cancer Liquid Biopsy Biomarkers' Clinical Utility in Diagnosis and Prognosis
    Matuszczak, Milena
    Schalken, Jack A.
    Salagierski, Maciej
    [J]. CANCERS, 2021, 13 (13)
  • [34] Urinary fatty acid biomarkers for prostate cancer detection
    Landa, Elizabeth Noriega
    Quaye, George E.
    Su, Xiaogang
    Badmos, Sabur
    Holbrook, Kiana L.
    Polascik, Thomas J.
    Adams, Eric S.
    Deivasigamani, Sriram
    Gao, Qin
    Annabi, Michael H.
    Habib, Ahsan
    Lee, Wen-Yee
    [J]. PLOS ONE, 2024, 19 (02):
  • [35] Biomarkers for Prostate Cancer Bone Metastasis Detection and Prediction
    Ying, Mingshuai
    Mao, Jianshui
    Sheng, Lingchao
    Wu, Hongwei
    Bai, Guangchao
    Zhong, Zhuolin
    Pan, Zhijun
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (05):
  • [36] PROSTATE CANCER EXOSOMES OFFERING NOVEL CIRCULATING BIOMARKERS FOR EARLY CANCER DIAGNOSIS AND PROGNOSIS
    Brennan, Samuel E.
    Nham Tran
    Clayton, Aled
    McGowan, Eileen M.
    Cozzi, Paul J.
    Martiniello-Wilks, Rosetta
    [J]. JOURNAL OF GENE MEDICINE, 2013, 15 (8-9): : 331 - 332
  • [37] Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer
    Njoku, Kelechi
    Sutton, Caroline J. J.
    Whetton, Anthony D.
    Crosbie, Emma J.
    [J]. METABOLITES, 2020, 10 (08) : 1 - 28
  • [38] Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis
    Herceg, Zdenko
    Hainaut, Pierre
    [J]. MOLECULAR ONCOLOGY, 2007, 1 (01) : 26 - 41
  • [39] Biomarkers for cancer risk, early detection, and prognosis: The validation conundrum
    Brenner, Dean E.
    Nortnolle, Daniel P.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (10) : 1918 - 1920
  • [40] BIOMARKERS FOR PROSTATE CANCER DETECTION AND, PROGRESSION: BEYOND PROSTATE-SPECIFIC ANTIGEN
    Berney, Daniel M.
    [J]. DRUG NEWS & PERSPECTIVES, 2010, 23 (03) : 185 - 194
12345